Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
346-360 of 437
When Breast Cancer Spreads to the Brain: Diagnosis and Treatment Strategies
Project Oncology®When Breast Cancer Spreads to the Brain: Diagnosis and Treatment Strategies
Pavani Chalasani, MD, MPH
Jose Pablo Leone, MD
Examining the Economic Impacts of Biosimilars in Oncology
Project Oncology®Examining the Economic Impacts of Biosimilars in Oncology
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Sophia Humphreys, PharmD, MHA, BCBBS
Approaches to Utilizing Bone-targeting Therapies in mBC
Project Oncology®Approaches to Utilizing Bone-targeting Therapies in mBC
Pavani Chalasani, MD, MPH
Gabriel N. Hortobagyi, MD
The Role of PARP Inhibitors in Metastatic Breast Cancer
Project Oncology®The Role of PARP Inhibitors in Metastatic Breast Cancer
Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Project Oncology®Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Pavani Chalasani, MD, MPH
Nick McAndrew, MD, MSCE
Diving into the Efficacy & Tolerability of mBC Treatment
Project Oncology®Diving into the Efficacy & Tolerability of mBC Treatment
Pavani Chalasani, MD, MPH
Colleen Bohnenkamp, PharmD, BCPS, BCOP
- advertisement
Investigating a Therapy for Brain Metastases: A Growing Problem
Project Oncology®Investigating a Therapy for Brain Metastases: A Growing Problem
Charles Turck, PharmD, BCPS, BCCCP
Priscilla Brastianos, MD
Study Shows Importance of Comprehensive Genomic Profiling for NSCLC
Project Oncology®Study Shows Importance of Comprehensive Genomic Profiling for NSCLC
Vivek Subbiah, MD
Exploring the Role of Biomarkers in Lung Cancer Treatment
Spotlight on Lung CancerExploring the Role of Biomarkers in Lung Cancer Treatment
Jacob Sands, MD
Biagio Ricciuti, MD
Key Insights on Screening for HPV-Positive Oropharynx Cancer
Project Oncology®Key Insights on Screening for HPV-Positive Oropharynx Cancer
Jacob Sands, MD
Eleni Rettig, MD
Exploring Fungi in Cancer-Type Tumors & Cancer Therapeutics
Project Oncology®Exploring Fungi in Cancer-Type Tumors & Cancer Therapeutics
Mario R. Nacinovich, Jr., MSc
Gregory Sepich-Poore, MD/PhD
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Project Oncology®Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Pavani Chalasani, MD, MPH
Hope S. Rugo, MD, FASCO
- advertisement
Recognizing the Role of Capmatinib for METex14 in NSCLC
Project Oncology®Recognizing the Role of Capmatinib for METex14 in NSCLC
Jacob Sands, MD
Edward B. Garon, MD, MS
Evaluating Landmark Clinical Data for HER2-low Breast Cancer
Project Oncology®Evaluating Landmark Clinical Data for HER2-low Breast Cancer
Pavani Chalasani, MD, MPH
Prof. David Cameron
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Project Oncology®Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Pavani Chalasani, MD, MPH
Erika Hamilton, MD